NeOnc Technologies Holdings, Inc.
PublicNeOnc Technologies Holdings, Inc. is now publicly traded
The data on this page reflects NeOnc Technologies Holdings, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series A
Convertible Preferred Stock
Jun 25, 2026
Total Funding Raised
$5M
Company Overview
NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company that focuses on the development and commercialization of central nervous system therapeutics designed to overcome the blood-brain barrier.
Sector
Healthcare
AI Layer
Non-AI
Keywords
NeOnc Technologies Holdings, Inc. Comparables
Compare NeOnc Technologies Holdings, Inc. with similar companies based on industry and business-model similarity.
No public comparables are available for NeOnc Technologies Holdings, Inc.. Request access to learn about comparables coverage.
Request accessNeOnc Technologies Holdings, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Convertible Preferred Stock | Jun 25, 2026 |
Key People
Founding team and executive leadership
NeOnc Technologies Holdings, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access